Go back

UK risks losing its lead in clinical research, warns ABPI report

Country needs to do more to avoid losing out to emerging competitors, says pharma industry

The UK leads Europe in early clinical research, but it now faces fresh challenges to stay globally competitive, according to data from the Association of the British Pharmaceutical Industry.

Its report, Clinical trials: How the UK is researching medicines of the future, shows that the UK ranks first in Europe for the number of early clinical trials, with 147 phase one trials and 253 phase two trials started in 2017. For phase three, 243 trials were started in the UK, with the UK ranking third in Europe behind Germany and Spain.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.